- External Relations
- University Responsibilities
(click to check for cognate researchers)
|Also Cited As:||
Dr Chan obtained his MBBS degree in King’s College London, University of London in 2001. He completed his surgical training in the Department of Surgery in Queen Mary Hospital, Hong Kong and attained his fellowship with the Royal College of Surgeons, Edinburgh and the College of Surgeons, Hong Kong in 2008. He became a faculty member in the Department of Surgery, The University of Hong Kong as Clinical Assistant Professor in 2009, and is currently a staff surgeon and honorary associate consultant for the Division of Hepatobiliary and Pancreatic Surgery, and Liver Transplantation in Queen Mary Hospital.
His research interests focus on the surgical management of hepatocellular carcinoma in particular salvage liver transplantation, laparoscopic liver resection and the development of tumor staging system. He pioneered the use of Associating Liver Partition and Portal Vein Ligation for staged hepatectomy in Hong Kong and first reported in the literature its application in a pediatric patient with hepatoblastoma. He was awarded the GB Ong Travelling Fellowship in 2014 and has won various clinical research awards including the best oral paper in The 11th World Congress of International Hepato-Pancreato-Biliary Association (IHPBA) 2014, the Best Oral Presentation in the 6th International Meeting "Hepatocellular Carcinoma: Eastern and Western Experiences" in 2008, and the Silver Award for the Best Research by Trainees in the Hong Kong Academy of Medicine in 2007. He was also awarded the best research output in the Department of Surgery, The University of Hong Kong in 2013.
As a current member of the working party in the acute-on-chronic liver failure consortium for Asia-Pacific Association of Study of Liver Disease (APASL), he is actively involved in the development of treatment guidelines for this condition.
Dr Chan has presented in various international meetings including the plenary session in the IHPBA World Congress 2012 and the best oral paper in the IHPBA World Congress 2014, one of the largest academic exchange activities in the field of HBP Surgery. He has also successfully acquired funding from the Research Grant Council in Hong Kong for a randomized control trial on portal vein embolization.. He is an invited reviewer for various peer-reviewed international journals such as Journal of Clinical Oncology and Liver Transplantation, and is actively engaged in clinical research with publications in numerous international surgical journals including Annals of Surgery, and Liver Transplantation.